Pascal Pfister

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

Kenneth R. Chapman, John R. Hurst, Stefan Frent et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 262 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Fixed-dose combination of indacaterol/glycopyrronium/mometasone furoate once-daily versus salmeterol/fluticasone twice-daily plus tiotropium once-daily in patients with uncontrolled asthma: A randomised, Phase IIIb, non-inferiority study (ARGON)

Oliver Kornmann, Jorge Máspero, Richard N. van Zyl-Smit et al. · Respiratory Medicine · 2020 · 81 citations

Pharmacy, Internal Medicine, Pharmacotherapy +11

Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma

Demosthenes Bouros, N. Bachlitzanakis, John Kottakis et al. · European Respiratory Journal · 1999 · 50 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Similar Bronchodilation with Formoterol Delivered by Aerolizer or Turbuhaler

Jan Lötvall, Á. Callejo Mellén, Peter Arvidsson et al. · Canadian Respiratory Journal · 1999 · 25 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

SIMILAR EFFICACY FOLLOWING FOUR WEEKS TREATMENT OF ASTHMATICS WITH FORMOTEROL 12 μG B.D. DELIVERED BY TWO DIFFERENT DRY POWDER INHALERS: DIFFERENCES IN INHALER HANDLING

A Eliraz, Alicia Ramírez‐Rivera, P Ferranti et al. · International Journal of Clinical Practice · 2001 · 21 citations

Pharmacy, Pharmacology, Pharmacotherapy +14